FDA approves triheptanoin (Dojolvi) as a source of calories and fatty acids for the treatment of long-chain fatty acid oxidation disorders (LC-FAOD)

Dojolvi is a 7-carbon fatty acid triglyceride which provides medium-chain, odd-carbon fatty acids (FAs) as energy source and metabolite replacement for people with this group of rare & life-threatening genetic disorders, who are unable to convert long-chain FAs into energy.


Biospace Inc.